The Department of Health Care Services posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal.
- Diabetic Supplies: Updates to Continuous Glucose Monitoring Systems (October 4)
- Medical Supplies: Continuous Glucose Monitoring Systems and Disposable Insulin Delivery Devices Updates (September 30; Revised October 4)
- Medi-Cal Rx Monthly Bulletin for October (October 1)
- Changes to Contract Drugs List (CDL) (October 1)
- Changes to Contract Drugs List (CDL) – Over-the-Counter Drugs (October 1)
- Changes to Contract Drugs List (CDL) – Authorized Drug Manufacturer Labeler Codes (October 1)
- Changes to Family PACT Pharmacy Formulary (October 1)
- Updates to the Medi-Cal Rx Provider Manual (October 1)
- Diabetic Supplies: Continuous Glucose Monitoring (CGM) Systems Billing Units Reminder, Effective October 1, 2022 (October 1)
- Enteral Nutrition Update: Changes to the List of Covered Enteral Nutrition Products, Effective November 1, 2022, December 1, 2022, and January 1, 2023 (October 1)
- Medical Supplies: Removal of Prior Authorization Requirement for Covered Blood Pressure Cuffs, Effective November 1, 2022 (October 1)
- Medical Supplies: Continuous Glucose Monitoring Systems and Disposable Insulin Delivery Devised Updates (September 30)
- Coming Soon: Bivalent COVID-19 Vaccines (September 30)
- Medi-Cal Rx Weekly Wrap-Up for September 23-29 (September 30)
Also in California, Medi-Cal posted the following:
- Policy Update and Billing Guidance for COVID-19 Oral Antiviral, Paxlovid
- 2022 HCPCS Quarter 4 Update
- 2023 ICD-10-CM/PCS Codes Update
- Medical Supplies Update: MAPC Change for Nonsterile Gloves
- Medi-Cal Update – Pharmacy – September 2022 – Bulletin 1024
Also in California, the Board of Pharmacy posted its Board of Pharmacy Update – October 2022.
In California, Medi-Cal Rx will provide an educational opportunity regarding Brand Medically Necessary Prior Authorizations (DAW 1) and implications for pharmacy providers related to the Dispense as Written (DAW), Brand Medically Necessary (BMN), and Reimbursement – Frequently Asked Questions (FAQs) and Submission of Pricing Prior Authorization for Brand Medically Necessary Medications: Dispense as Written 1 (DAW1), released on September 29. Please join the Zoom meeting on October 10 at 1:00 p.m. Pacific using the following:
https://magellanhealth.zoom.us/j/93157317543?pwd=ZzlGRE9FNWtZWWtqb2FRZzcyMmE3Zz09&from=addon
Password: 924224
or iPhone one-tap (US Toll): +16699006833,93157317543# or +13462487799,93157317543#
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.